GF Fund Management’s Genmab GMAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.9K Buy
1,484
+120
+9% +$3.8K ﹤0.01% 387
2026
Q2
$37.5K Buy
1,364
+51
+4% +$1.36K ﹤0.01% 425
2026
Q1
$35.2K Buy
1,313
+165
+14% +$4.94K ﹤0.01% 440
2025
Q4
$35.4K Buy
1,148
+248
+28% +$7.73K ﹤0.01% 444
2025
Q3
$27.6K Sell
900
-173
-16% -$4.22K ﹤0.01% 452
2025
Q2
$22.2K Hold
1,073
– – ﹤0.01% 491
2025
Q1
$21K Buy
1,073
+193
+22% +$4.05K ﹤0.01% 497
2024
Q4
$18.4K Buy
+880
New +$19.3K ﹤0.01% 479

Other funds holding GMAB

GF Fund Management's GMAB Position: Q3 2026 in Review

GF Fund Management increased its Genmab (GMAB) stake by 8.8% in Q3 2026, buying an estimated $3.8K and bringing the position to 1,484 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #387.

GF Fund Management first reported a position in GMAB in Q4 2024 and has held it in 8 quarters since. 137 funds tracked by Wall St. Rank hold GMAB as of Q3 2026.

  • GF Fund Management held 1,484 shares of Genmab worth $52.9K as of Q3 2026.
  • GF Fund Management bought 120 Genmab shares in Q3 2026, an estimated $3.8K.
  • Genmab made up ﹤0.01% of GF Fund Management's portfolio in Q3 2026, its #387 holding.
  • GF Fund Management first reported a position in Genmab in Q4 2024 and has held it in 8 quarters since.
  • 137 funds tracked by Wall St. Rank held Genmab as of Q3 2026.

Based on GF Fund Management's 13F filing for Q3 2026, filed 26 Oct 2026.